International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2013 - Volume 17, Number 5
View All Articles in Issue

Page(s): 356

PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: regulation, U.S. Food and Drug Administration, FDA, regulatory agency, compounded sterile preparations, quality control, drug safety, good manufacturing practices, good compounding practices, GMP, GCP, United States Pharmacopeia, USP

Related Categories: LEGAL, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Allen Loyd V Jr	Sep/Oct 2013 Pg. 356
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Allen Loyd V Jr	May/Jun 2013 Pg. 210-219
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM	Mar/Apr 2014 Pg. 101-111
PostScription: GMPs and GCPs: A Topical Comparison Allen Loyd V Jr	Jan/Feb 2013 Pg. 87
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Documentation: Records and Reports Akers Michael J	Sep/Oct 2017 Pg. 373-380
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Allen Loyd V Jr	Sep/Oct 2013 Pg. 439
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Allen Loyd V Jr	Mar/Apr 1997 Pg. 75-77
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
PreScription: Compounded Drugs Often Become Manufactured Drugs Allen Loyd V Jr	Nov/Dec 2022 Pg. 444
PreScription: Compounding for Drug Shortages Allen Loyd V Jr	May/Jun 2013 Pg. 180
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Martin Matt	Jan/Feb 2019 Pg. 47-49
Return to Top